Natalia A. Delgado Quiroz

Natalia A. Delgado Quiroz

Auto-generated profile, based on publicly available information

Natalia A. Delgado Quiroz

Department of Epidemiology, Universidad El Bosque, Bogotá, Colombia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ARAlejandro Rico-Mendoza
Alejandro Rico-Mendoza
APAlexandra Porras-Ramirez
Alexandra Porras-Ramirez
HGHeidy García-Orozco
Heidy García-Orozco
NDNatalia Delgado-Quiroz
Natalia Delgado-Quiroz
LELiliana Encinales
Liliana Encinales
JUJorge Urquijo-Mendez
Jorge Urquijo-Mendez
Sickle cell disease (SCD) is one of the most prevalent hemoglobinopathies worldwide, particularly in regions with high genetic predisposition. Early diagnosis through newborn screening (NBS) is critical for initiating interventions that significantly reduce morbidity and mortality. This systematic review evaluates the current methodologies used in NBS for SCD, comparing their sensitivity, specificity, and feasibility of implementation in different settings. We also explore recent innovations, including point-of-care (POC) tests and molecular diagnostics, that are transforming early detection strategies. Our findings suggest that while high-performance liquid chromatography (HPLC) and tandem mass spectrometry (MS/MS) remain gold-standard techniques, newer POC assays offer promising alternatives for resource-limited settings. The integration of artificial intelligence (AI) and genomic screening could further enhance diagnostic accuracy and accessibility. Future directions should focus on optimizing screening programs for global implementation and ensuring equity in early diagnosis.

2 June 2026 in World Neurosurgery
Verified
Journal Article
Open access
JRJuan Fernando Ramón-Cuellar
Juan Fernando Ramón-Cuellar
FHFernando Hakim
Fernando Hakim
DGDiego Gómez-Amarillo
Diego Gómez-Amarillo
APAlexandra Porras-Ramírez
Alexandra Porras-Ramírez
ARAlejandro Rico-Mendoza
Alejandro Rico-Mendoza
MCMaría F. Campos-Maya
María F. Campos-Maya
Three minimally invasive lumbar decompression strategies-unilateral hemilaminectomy (UH), unilateral biportal endoscopic decompression (UBE), and percutaneous transforaminal endoscopic surgery (PTES)-are widely used for lumbar degenerative disease, but pathology-stratified comparative evidence remains limited. To compare clinical efficacy, perioperative efficiency, and safety of UH, UBE, and PTES, and to explore whether comparative effect estimates vary by pathology subtype. PRISMA 2020 meta-analysis (PROSPERO CRD420261379841). Six databases (2020-2024) were screened for prospective comparative studies (≥30 patients/arm; ≥6-month follow-up). Risk of bias was assessed using RoB 2, NOS, and ROBINS-I. Random-effects REML models with Hartung-Knapp adjustment were applied; three-arm trials were handled per Cochrane §23.1. MCIDs were pre-specified (ODI=10; VAS-leg=1.5; VAS-back=2). Subgroup analyses were exploratory. Twenty-two studies (8 RCTs, 14 cohorts; N=3,362) were included. UBE and PTES were associated with statistically significant, below-MCID reductions in 12-month ODI versus UH (UBE: MD -5.8, 95% CI -8.1 to -3.5; PTES: MD -3.2, 95% CI -5.4 to -1.0). Exploratory pathology-stratified analyses suggested between-stratum variation in point estimates. Endoscopic techniques reduced overall complications (RR 0.62, 95% CI 0.46-0.83), PTES dural tear (RR 0.43, 95% CI 0.27-0.69), and reoperation (RR 0.55, 95% CI 0.40-0.76). GRADE certainty ranged from moderate to high. Pooled ODI differences remained below MCID thresholds and do not support strong recommendations for technique selection. Exploratory pathology-related signals require confirmation in adequately powered randomized trials. Observed differences in perioperative efficiency and complication profiles may nevertheless contribute to multidisciplinary surgical planning and individualized anatomical decision-making in selected patients with lumbar degenerative disease during clinical practice.

25 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JCJuan F. Ramón Cuellar
Juan F. Ramón Cuellar
FHFernando Hakim
Fernando Hakim
DADiego Gómez Amarillo
Diego Gómez Amarillo
NQNatalia A. Delgado Quiroz
Natalia A. Delgado Quiroz
APAlexandra Porras-Ramirez
Alexandra Porras-Ramirez
DHDaniela Rojas Herrera
Daniela Rojas Herrera
Pediatric hydrocephalus remains a common and complex condition in neurosurgical practice. Endoscopic Third Ventriculostomy (ETV) and Ventriculoperitoneal Shunting (VPS) are the two primary surgical modalities. While VPS has traditionally been the standard of care, ETV offers potential benefits in selected patients, particularly by reducing shunt dependency and infection risk. However, literature presents variable outcomes based on age, etiology, and study design. Methods: We conducted a systematic review and meta-analysis comparing ETV and VPS in pediatric patients (≤18 years) with hydrocephalus. Databases searched included PubMed, Embase, Cochrane Library, and Web of Science (2010–2024). Inclusion criteria covered studies with direct ETV vs. VPS comparison, and outcomes including treatment success, complications, and long-term prognosis. We performed heterogeneity analysis (I 2 ), sensitivity analysis, and meta-regression to explore study-level moderators such as age, sample size, and risk of bias. Results: Nine studies were included (N = 13,509; 6,365 ETV and 7,144 VPS patients). ETV demonstrated lower infection and shunt dependency rates, especially in patients over 1 year of age and in cases of obstructive hydrocephalus. VPS had slightly higher short-term success, particularly in post-hemorrhagic etiologies. Meta-regression revealed that higher bias and smaller sample sizes favored VPS outcomes (β = −0.065). ETV showed better long-term cognitive and quality-of-life outcomes. Heterogeneity was low to moderate (I 2 = 22.5%). Conclusions: ETV is an effective alternative to VPS in appropriately selected pediatric patients, particularly those older than 6 months with obstructive hydrocephalus. The benefits include lower infection rates and long-term dependency. However, the success of ETV is highly dependent on patient selection and surgical expertise. This review underscores the need for standardized reporting, stratification by age and etiology, and high-quality randomized controlled trials to guide clinical decision-making.